Company Encyclopedia
View More
name
JD HEALTH
06618.HK
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People’s Republic of China. It provides online medical consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services, as well as internet healthcare, health management, intelligent healthcare, advertising, and technical services. The company also offers home care services, including wound care, blood tests and diagnostics, post-operative care, and medical escort; online medical insurance payment services; and smart healthcare and digital health solutions. In addition, it provides online marketing services to advertisers; and online shopping and hospital services.
310.87 B
06618.HKMarket value -Rank by Market Cap -/-

Financial Score

10/12/2025 Update
B
Drug RetailIndustry
Industry Ranking1/7
Industry medianB
Industry averageB
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE8.58%B
    • Profit Margin7.25%B
    • Gross Margin25.20%C
  • Growth ScoreA
    • Revenue YoY19.07%B
    • Net Profit YoY80.63%A
    • Total Assets YoY18.90%A
    • Net Assets YoY13.26%B
  • Cash ScoreB
    • Cash Flow Margin1379.04%B
    • OCF YoY19.07%B
  • Operating ScoreB
    • Turnover0.89B
  • Debt ScoreB
    • Gearing Ratio26.11%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    JD Health International Inc. held extraordinary general meeting

    JD Health International Inc. held an extraordinary general meeting on December 8, 2025, where shareholders approved proposals including an agreement with JD.com for healthcare products and services, and related annual caps for the next three years.

    Reuters·
    HK
    06618
    -0.84%
    Reuters·
    HK
    06618
    -0.84%

    Stock Analysis: JD Health International

    JD Health International, a leading online healthcare platform in China, has shown World Class performance in growth, ranking 1st among peers, and improved profitability, ranking 3rd. The company's market cap is US$28,537m, and it operates in online consultations, pharmaceutical sales, and health management. The growth rank improved from 2nd to 1st, while profitability improved from 4th to 3rd, indicating above-average performance compared to 540 large Cons. Staples companies worldwide.

    Talkmarkets·
    HK
    06618
    -0.84%
    Talkmarkets·
    HK
    06618
    -0.84%

    JD HEALTH has reached a strategic cooperation on pet health care with multinational pharmaceutical company Boehringer Ingelheim

    JD HEALTH has reached a strategic cooperation with Boehringer Ingelheim, and the two parties will collaborate deeply in areas such as omnichannel supply chain, brand co-construction, and user services to promote the development of the pet healthcare business in China. JD HEALTH CEO Cao Dong stated that they will work with global pharmaceutical companies to improve the matrix of pet health products and services. Previously, Boehringer Ingelheim's pet products performed excellently on the JD HEALTH platform. This cooperation is expected to enhance supply chain efficiency and the quality of business growth

    AASTOCKS·
    HK
    06618
    -0.84%
    AASTOCKS·
    HK
    06618
    -0.84%

    JD.com plans to raise over 7.8 billion yuan through a share swap bond, intending to exchange it for JD HEALTH

    JD.com plans to issue convertible bonds to raise at least USD 1 billion, which will be exchanged for JD HEALTH shares, effectively reducing its holdings. JD.com holds 67.16% of JD HEALTH shares and plans to reduce its stake to 63.2%. Alibaba and Baidu have also reduced their subsidiary holdings through convertible bonds

    Stheadline·
    US
    JD
    -0.05%
    HK
    09618
    -0.09%
    HK
    06618
    -0.84%
    Stheadline·
    US
    JD
    -0.05%
    HK
    09618
    -0.09%
    HK
    06618
    -0.84%

    Hang Seng Plunges to Close at 5-Week Low

    The Hang Seng index dropped 615 points, or 2.4%, to 25,220, marking a 5-week low. Losses were broad-based, with tech, consumer, property, and financial sectors falling sharply. Hong Kong's markets fell 5.1% weekly amid Tokyo-Beijing tensions. Major decliners included JD Health, SMIC, China Hongqiao, and Galaxy Entertainment.

    Trading Economics·
    HK
    06618
    -0.84%
    Trading Economics·
    HK
    06618
    -0.84%
    Posts
    View More

    $XTALPI(02228.HK) Goldman Sachs launched the "China AI Healthcare Index" today, with Pharmaron as the top-weighted stock $ALI HEALTH(00241.HK)$JD HEALTH(06618.HK)$PA GOODDOCTOR(01833.HK)$YIDU TECH(021...

    • 0
    © 2025 Longbridge｜Disclaimer